Gastrointestinal Transit Abnormalities Associated With Severe GI Symptoms in Scleroderma
Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms.
Systemic Sclerosis
Assessing the Long-Term Safety and Efficacy of Tocilizumab in Systemic Sclerosis
The long-term safety and efficacy of tocilizumab in patients with systemic sclerosis were assessed in an open-label study.
Higher Neutrophil Count Linked to Mortality in Systemic Sclerosis-Related Interstitial Lung Disease
A higher neutrophil count predicted worse disease course and higher long-term mortality in patients with systemic sclerosis-related interstitial lung disease.
Iloprost Can Reverse Vascular Dysfunction in Scleroderma
Researchers evaluated the cellular mechanism of iloprost in reversing vascular dysfunction in scleroderma.
Evaluating Novel Classifications for Systemic Sclerosis
Recent studies have evaluated new approaches to understand the heterogeneity of systemic sclerosis by optimizing disease classification.
Gene Expression in Patients With Severe Scleroderma May Predict Stem Cell Transplant Response
Researchers determined whether machine learning could predict stem cell transplant response in severe scleroderma.
Adverse Event Profile of Nintedanib in SSc-ILD Consistent With its Safety, Tolerability Profile in Idiopathic Pulmonary Fibrosis
Researchers characterized the safety and tolerability of nintedanib and the dose adjustments for adverse events in patients with systemic sclerosis-associated interstitial lung disease.
Systemic Sclerosis Mortality Data Reveals Trends Over 48 Years
Researchers identified secular trends associated with systemic sclerosis mortality over 48 years.
Role of Lung Ultrasound in the Assessment of Interstitial Lung Disease in Systemic Sclerosis
In this systematic review, researchers assessed the role of lung ultrasound in the assessment of interstitial lung disease in systemic sclerosis.
Antibody Response Against Human Cytomegalovirus Differs by Anti-Ro52 Antibody Status in SSc
Researchers investigated the association between anti-Ro52 antibodies with responses to specific human cytomegalovirus antigens in systemic sclerosis and lupus.
-
Loading...
-
Loading...
